Written by top practitioners in the field of neuropsychological screening, Screening for Brain Impairment is the extensively updated new edition of the classic resource. Valuable to a broad range of medical and mental health practitioners, this new edition reflects enormous changes to the field over the past 13 years. Each chapter contains updated information and new empirical data, including extensive information on neurological and psychiatric disorders, adult attention deficit disorder, and screening for and assessing the emotional correlates of brain impairment. Also included are new chapters on computerized assessment and developing relations with other professionals, including clinical neuropsychologists, neurologists, primary care physicians, neurosurgeons, and psychiatrists.
Written for graduate students and trainees in mental health, this is the only text to present neurobiology in the context of clinical issues rather than merely focusing on experimental approaches to biological psychology or structuring it along neurological systems. In clear, easily accessible language the text explains how the brain and nervous system are linked to mental disorders. It integrates information from many aspects of neurobiological research, including imaging, neuropsychology, and genetics in order to foster an in-depth understanding of the psychiatric presentation of disorders that mental health professionals encounter in their practices. To facilitate student learning and clarify the connection between neurobiological foundations and clinical presentation, the text includes case studies, cognitive data, imaging results, genetic testing results, and illustrations. It examines major psychological disorders from behavioral, emotional, biological, cognitive and neurophysiological perspectives as they relate to brain structure and the major systems. Special topic sections highlight ethical, research, and treatment concerns for mental health practitioners. Each chapter concludes with summations and review questions. Written for graduate level students in clinical, counseling, and school psychology programs, the text fulfills APA accreditation requirements for coursework in the biological bases of behavior. While the textís primary aim is to help students understand neurobiological information as an important component of a therapeutic framework, it also concisely addresses micro and macro anatomy as relates to neurobiology. Also included are such supplementary teaching materials as test questions and PowerPoint slides of illustrations. Key Features: Focuses on the connection between neurobiology and clinical presentation Presents complex information clearly and concisely Highlights special topics in neurobiology ethics, research, and treatment Integrates information from imaging, neuropsychology, and genetics testing Prepares graduate students in clinical, counseling, and school psychology for professional practice
A long-standing tradition of excellence is extended in the Fourth Edition of this authoritative introduction to the field of therapeutic recreation. The authors effectively combine a broad orientation to the profession with the practical information necessary for students to become successful practitioners. Part I contains a comprehensive discussion of the fields history and theoretical underpinnings, providing students with the perspective they need to evaluate the social, cultural, demographic, economic, and technical forces that have shaped and are continuing to impact health and human services in general, and therapeutic recreation in particular. Part II introduces students to the client populations served by therapeutic recreation specialists and describes specific approaches and activities employed by TR professionals to help clients achieve meaningful improvements in health status, functional capacities, and quality of life. The authors have retained the practical, student-oriented approach that makes this an ideal text for introductory courses. They address all content areas included in the NCTRC certification exam, are compatible with the American Psychiatric Association on psychological classifications, and incorporate the World Health Organizations international classification of functioning, disability, and health. The latest edition contains updated information on baby boomers, the obesity epidemic, and evidence-based practices; field-based photographs and illustrations; and study questions and exercises designed to engage students.
We often think of the apostles as spiritual giants—men who were uniquely qualified to walk with Jesus and carry on His mission to the world. But the reality is they stand out more for their lack of qualifications. They were not trained religious scholars; they often misunderstood what Jesus told them; and sometimes they simply failed to live up to Jesus’s expectations. Not only did they lack qualifications, but they also encountered many of the same fears and issues we experience. They struggled with doubts, cowardice, ambition, faithlessness, pessimism, and greed. In other words, the apostles were people just like us. Yet, Jesus chose them to change the world. And they did. Lessons from the Apostles describes the struggles and personalities of these ordinary men, reveals the transformation Jesus made in their lives, and identifies specific lessons you can apply in your own life. You will also find brief accounts of the stories and legends regarding what happened to the apostles after the Bible. As you read about each of these men, you will likely recognize your own personality in one or more of them. And you will find encouragement from knowing that you too are the type of person God can use to change the world
A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The arrival of new information technology (infotech) companies on the healthcare scene presents both opportunities and challenges for the biopharma business model. To capitalize on new digital technologies from R&D through commercialization requires industry leaders to adopt new business models, develop new digital and data capabilities, and partner with innovators and payers worldwide. Written by two experts, both of whom have had decades of experience in the field, this book provides a comprehensive overview of the new business context and marketing models for biotech companies. Informed by extensive input by senior biotech executives and leading consultancies serving the industry, it analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. JACQUALYN FOUSE, PhD, RETIRED PRESIDENT AND CHIEF OPERATING OFFICER, CELGENE “Biotech companies have long been innovators, using the latest technologies to enable cutting edge science to help patients with serious diseases. This book is essential to help biotech firms understand how they can–and must–apply the newest technologies including disruptive ones, alongside science, to innovate and bring new value to the healthcare system.” BRUCE DARROW, MD, PhD, CHIEF MEDICAL INFORMATION OFFICER, MOUNT SINAI HEALTH SYSTEM “Simon and Giovannetti have written an essential user’s manual explaining the complicated interplay of the patients who deserve cutting-edge medical care, the biotechnology companies (big and small) creating the breakthroughs, and the healthcare organizations and clinicians who bridge those worlds.” EMMANUEL BLIN, FORMER CHIEF STRATEGY OFFICER AND SENIOR VICE PRESIDENT, BRISTOL-MYERS SQUIBB “If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about.” JOHN MARAGANORE, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALNYLAM PHARMACEUTICALS “Since the mapping of the human genome was completed nearly 15 years ago, the biotechnology industry has led the rapid translation of raw science to today’s innovative medicines. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book.”
Thoroughly revised and updated for its Fourth Edition, this highly acclaimed volume is the most comprehensive reference on hospital epidemiology and infection control. Written by over 150 leading experts, this new edition examines every type of hospital-acquired (nosocomial) infection and addresses every issue relating to surveillance, prevention, and control of these infections in patients and in healthcare workers. This new edition features new or significantly increased coverage of emerging infectious diseases, avian influenza, governmental regulation of infection control and payment practices related to hospital-acquired infections, molecular epidemiology, the increasing prevalence of community-acquired MRSA in healthcare facilities, system-wide infection control provisions for healthcare systems, hospital infection control issues following natural disasters, and antimicrobial stewardship in reducing the development of antimicrobial-resistant organisms.
Human adenoviruses play a central role in human diseases and as vectors for vaccines and gene delivery. This monograph describes the underlying principles of adenovirus molecular and structural biology, pathogenesis, antiviral measures and vector development. Much of the history of this virus and the many contributions made by its study are embedded in these discussions. Topics and questions that require further investigation are also considered.Although current virology textbooks cover topics related to adenoviruses, this book provides a comprehensive description of the virus and its interactions with the host. Students and researchers with a particular interest in adenoviruses, gene therapists, and virologists interested in viral pathogenesis will benefit from this book, which presents a unique integration of the basics with applied research in the field.
The Advantage Series presents the Feature-Method-Practice approach to computer software applications to today's technology and business students. This series implements an efficient and effective learning model, which enhances critical thinking skills and provides students and faculty with complete application coverage.The primary market is the Introduction to Computing/CIS computer literacy course requiring a lab component that covers software applications.Other course areas include Adult and Continuing Education/Individual Application courses, which are one-credit hour, designed to provide a brief introduction to a single software application.
The Advantage Series presents the Feature-Method-Practice approach to computer software applications to today's technology and business students. This series implements an efficient and effective learning model, which enhances critical thinking skills and provides students and faculty with complete application coverage.The primary market is the Introduction to Computing/CIS computer literacy course requiring a lab component that covers software applications.Other course areas include Adult and Continuing Education/Individual Application courses, which are one-credit hour, designed to provide a brief introduction to a single software application.
The Advantage Series presents the Feature-Method-Practice approach to computer software applications to today's technology and business students. This series implements an efficient and effective learning model, which enhances critical thinking skills and provides students and faculty with complete application coverage.
The Advantage Series presents the Feature-Method-Practice approach to computer software applications to today's technology and business students. This series implements an efficient and effective learning model, which enhances critical thinking skills and provides students and faculty with complete application coverage.
Written by top practitioners in the field of neuropsychological screening, Screening for Brain Impairment is the extensively updated new edition of the classic resource. Valuable to a broad range of medical and mental health practitioners, this new edition reflects enormous changes to the field over the past 13 years. Each chapter contains updated information and new empirical data, including extensive information on neurological and psychiatric disorders, adult attention deficit disorder, and screening for and assessing the emotional correlates of brain impairment. Also included are new chapters on computerized assessment and developing relations with other professionals, including clinical neuropsychologists, neurologists, primary care physicians, neurosurgeons, and psychiatrists.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.